A Randomized, Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss.
Greenway, Frank L
A Randomized, Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss. [electronic resource] - Obesity (Silver Spring, Md.) 02 2019 - 205-216 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1930-739X
10.1002/oby.22347 doi
Administration, Oral
Double-Blind Method
Female
Humans
Hydrogels--pharmacology
Male
Middle Aged
Obesity--drug therapy
Weight Loss--physiology
A Randomized, Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss. [electronic resource] - Obesity (Silver Spring, Md.) 02 2019 - 205-216 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1930-739X
10.1002/oby.22347 doi
Administration, Oral
Double-Blind Method
Female
Humans
Hydrogels--pharmacology
Male
Middle Aged
Obesity--drug therapy
Weight Loss--physiology